{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T05:48:01Z","timestamp":1792648081367,"version":"4.5.0"},"reference-count":226,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012576","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"publisher","award":["2025B1515020074"],"award-info":[{"award-number":["2025B1515020074"]}],"id":[{"id":"10.13039\/501100012576","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272144"],"award-info":[{"award-number":["82272144"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20250526161328004"],"award-info":[{"award-number":["JCYJ20250526161328004"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20230807091404010"],"award-info":[{"award-number":["JCYJ20230807091404010"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20220530143411025"],"award-info":[{"award-number":["JCYJ20220530143411025"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025J09009"],"award-info":[{"award-number":["2025J09009"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bioactmat.2026.06.040","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T20:56:30Z","timestamp":1782593790000},"page":"112-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Immune cell-derived membrane nanovesicles: A promethean fire for autoimmune disease therapy through immune cell mimicry"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3020-6424","authenticated-orcid":false,"given":"Yan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1279-2397","authenticated-orcid":false,"given":"Nasrullah","family":"Jan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2613-7286","authenticated-orcid":false,"given":"Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1951-2375","authenticated-orcid":false,"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioactmat.2026.06.040_bib1","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.4110\/in.2022.22.e10","article-title":"Recent advances in cell therapeutics for systemic autoimmune diseases","volume":"22","author":"Park","year":"2022","journal-title":"Immune Netw."},{"issue":"6","key":"10.1016\/j.bioactmat.2026.06.040_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103326","article-title":"Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019","volume":"22","author":"Cao","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102266","article-title":"The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention","volume":"80","author":"Miller","year":"2023","journal-title":"Curr. Opin. Immunol."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.06.040_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cell.2020.03.007","article-title":"Challenges, progress, and prospects of developing therapies to treat autoimmune diseases","volume":"181","author":"Fugger","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bioactmat.2026.06.040_bib5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-024-01952-8","article-title":"Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders","volume":"9","author":"Song","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.06.040_bib6","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.4110\/in.2022.22.e9","article-title":"Targeted immunotherapy for autoimmune disease","volume":"22","author":"Jung","year":"2022","journal-title":"Immune Netw."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1189142","article-title":"Efficacy and safety of iguratimod in the treatment of rheumatic and autoimmune diseases: a meta-analysis and systematic review of 84 randomized controlled trials","volume":"14","author":"Zeng","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.06.040_bib8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s41232-021-00179-2","article-title":"Genome-oriented treatment strategies for autoimmune diseases","volume":"41","author":"Tanaka","year":"2021","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib9","unstructured":"Yasir M., A. Goyal, and S. Sonthalia, Corticosteroid adverse effects, in StatPearls. 2025, StatPearls publishing copyright \u00a9 2025, StatPearls publishing LLC.: treasure island (FL) ineligible companies. Disclosure: Amandeep Goyal Declares No Relevant Financial Relationships with Ineligible Companies. Disclosure: Sidharth Sonthalia Declares No Relevant Financial Relationships with Ineligible Companies."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.06.040_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.trim.2006.09.018","article-title":"Gema Salgado cecilia, and pascual parrilla paricio, Long-term problems related to immunosuppression","volume":"17","author":"Manuel Miras","year":"2006","journal-title":"Transpl. Immunol."},{"issue":"6","key":"10.1016\/j.bioactmat.2026.06.040_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202238","article-title":"Tissue-targeted drug delivery strategies to promote antigen-specific immune tolerance","volume":"12","author":"Rui","year":"2023","journal-title":"Adv. Healthcare Mater."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.06.040_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202149675","article-title":"Targeting B cells and plasma cells in autoimmune diseases: from established treatments to novel therapeutic approaches","volume":"53","author":"Merino-Vico","year":"2023","journal-title":"Eur. J. Immunol."},{"issue":"11","key":"10.1016\/j.bioactmat.2026.06.040_bib13","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1136\/ard-2024-225727","article-title":"B-cell depletion in autoimmune diseases","volume":"83","author":"Schett","year":"2024","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.06.040_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-immunol-083122-044829","article-title":"B cell-directed therapy in autoimmunity","volume":"42","author":"Abeles","year":"2024","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib15","article-title":"Cell membrane-derived vesicle: a novel vehicle for cancer immunotherapy","volume":"13","author":"Xu","year":"2022","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.bioactmat.2026.06.040_bib16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri2567","article-title":"Membrane vesicles as conveyors of immune responses","volume":"9","author":"Th\u00e9ry","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.bioactmat.2026.06.040_bib17","article-title":"Tumor cell membrane-based vaccines: a potential boost for cancer immunotherapy","volume":"4","author":"Yang","year":"2024","journal-title":"Exploration (Beijing)"},{"issue":"6","key":"10.1016\/j.bioactmat.2026.06.040_bib18","article-title":"Recent applications of immunomodulatory biomaterials for disease immunotherapy","volume":"2","author":"Dai","year":"2022","journal-title":"Exploration (Beijing)"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib39","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/10717544.2020.1748758","article-title":"Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source","volume":"27","author":"Wanrong","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib40","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","article-title":"Extracellular vesicles as a next-generation drug delivery platform","volume":"16","author":"Herrmann","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-023-04859-2","article-title":"High efficiency preparation of monodisperse plasma membrane derived extracellular vesicles for therapeutic applications","volume":"6","author":"Alter","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib42","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/j.apsb.2021.01.020","article-title":"Cell membrane-derived vesicles for delivery of therapeutic agents","volume":"11","author":"Quoc-Viet","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/nano13202751","article-title":"Engineering cell-derived nanovesicles for targeted immunomodulation","volume":"13","author":"Sayyed","year":"2023","journal-title":"Nanomaterials"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib44","article-title":"Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy","volume":"18","author":"Chunai","year":"2020","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib45","first-page":"716","article-title":"Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system","volume":"13","author":"Hui","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib46","first-page":"33","article-title":"Targeting drugs to tumours using cell membrane-coated nanoparticles","volume":"20","author":"Ronnie","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.bioactmat.2026.06.040_bib47","first-page":"546","article-title":"Cell membrane coated nanocarriers - an efficient biomimetic platform for targeted therapy","volume":"327","author":"Pratigyan","year":"2020","journal-title":"J. Contr. Release : Off. J. Contr. Rel. Soc."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2020.05.028","article-title":"Hybrid cell membrane-coated nanoparticles: a multifunctional biomimetic platform for cancer diagnosis and therapy","volume":"112","author":"Chen","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2024.113893","article-title":"Biomembrane camouflaged nanoparticles: a paradigm shifts in targeted drug delivery system","volume":"238","author":"Qureshi","year":"2024","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib50","article-title":"Hybrid cell membrane\u2010coated nanoparticles for biomedical applications","volume":"5","author":"Yiyan","year":"2024","journal-title":"Small Struct."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib51","doi-asserted-by":"crossref","first-page":"17802","DOI":"10.1021\/acsnano.2c08774","article-title":"Exosomes\u2014Nature\u2019s lipid nanoparticles, a rising star in drug delivery and diagnostics","volume":"16","author":"Rumiana","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib19","article-title":"Cell membrane-derived nanovesicles as extracellular vesicle-mimetics in wound healing","volume":"31","author":"Wenwen","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pharmthera.2017.02.020","article-title":"Exosomes: therapy delivery tools and biomarkers of diseases","volume":"174","author":"Barile","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib21","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jconrel.2016.01.024","article-title":"Cell membrane-formed nanovesicles for disease-targeted delivery","volume":"224","author":"Jin","year":"2016","journal-title":"J. Contr. Release : Off. J. Contr. Rel. Soc."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib22","article-title":"Bioinspired engineering of fusogen and targeting moiety equipped nanovesicles","volume":"14","author":"Lixue","year":"2023","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bioactmat.2026.06.040_bib23","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.ymthe.2022.10.008","article-title":"Cell-derived nanovesicle-mediated drug delivery to the brain: principles and strategies for vesicle engineering","volume":"31","author":"Liang","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib24","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.cell.2025.01.021","article-title":"Neutrophil-derived vesicles control complement activation to facilitate inflammation resolution","volume":"188","author":"Hsu","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib25","doi-asserted-by":"crossref","first-page":"102530","DOI":"10.1016\/j.nantod.2024.102530","article-title":"ROS-responsive biomimetic nanovesicles to plaque microenvironment in targeted therapy of atherosclerosis","volume":"59","author":"Zhanhao","year":"2024","journal-title":"Nano Today"},{"issue":"1","key":"10.1016\/j.bioactmat.2026.06.040_bib26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12951-021-01231-6","article-title":"Nanoparticles functionalized with stem cell secretome and CXCR4-overexpressing endothelial membrane for targeted osteoporosis therapy","volume":"20","author":"Zhang","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"21","key":"10.1016\/j.bioactmat.2026.06.040_bib27","article-title":"Genetically engineered cellular membrane vesicles as tailorable shells for therapeutics","volume":"8","author":"Ren","year":"2021","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib28","article-title":"Microneedle-based delivery of cell membrane vesicles as IL-17RA decoys for psoriasis treatment","volume":"24","author":"Bin","year":"2026","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib29","article-title":"Replenishing decoy extracellular vesicles inhibits phenotype remodeling of tissue-resident cells in inflammation-driven arthritis","volume":"4","author":"Mengmeng","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib30","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jconrel.2024.03.007","article-title":"Immune cell-derived extracellular vesicles for precision therapy of inflammatory-related diseases","volume":"368","author":"Shuo","year":"2024","journal-title":"J. Contr. Release : Off. J. Contr. Rel. Soc."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.06.040_bib31","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1186\/s12951-022-01660-x","article-title":"Targeting Myd88 using peptide-loaded mesenchymal stem cell membrane-derived synthetic vesicles to treat systemic inflammation","volume":"20","author":"Park","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"3","key":"10.1016\/j.bioactmat.2026.06.040_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202200925","article-title":"Engineered cell membrane vesicles expressing CD40 alleviate system lupus nephritis by intervening B cell activation","volume":"7","author":"Fang","year":"2023","journal-title":"Small Methods"},{"issue":"31","key":"10.1016\/j.bioactmat.2026.06.040_bib33","article-title":"Macrophage-mimicking cellular nanoparticles scavenge proinflammatory cytokines in specimens of patients with inflammatory disorders","volume":"11","author":"Zhou","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"1","key":"10.1016\/j.bioactmat.2026.06.040_bib34","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1038\/s41467-020-16439-7","article-title":"Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines","volume":"11","author":"Gao","year":"2020","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.bioactmat.2026.06.040_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202301178","article-title":"Macrophage-biomimetic nanoplatform-based therapy for inflammation-associated diseases","volume":"8","author":"Qu","year":"2024","journal-title":"Small Methods"},{"issue":"50","key":"10.1016\/j.bioactmat.2026.06.040_bib36","doi-asserted-by":"crossref","first-page":"46222","DOI":"10.1021\/acsomega.2c04420","article-title":"Dendritic cell membrane-derived nanovesicles for targeted T cell activation","volume":"7","author":"Harvey","year":"2022","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.bioactmat.2026.06.040_bib37","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1080\/10717544.2022.2117434","article-title":"Recent trends in platelet membrane-cloaked nanoparticles for application of inflammatory diseases","volume":"29","author":"Fang","year":"2022","journal-title":"Drug Deliv."},{"issue":"2","key":"10.1016\/j.bioactmat.2026.06.040_bib38","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1021\/acsnano.3c09848","article-title":"Engineered biomimetic nanovesicles based on neutrophils for hierarchical targeting therapy of acute respiratory distress syndrome","volume":"18","author":"Li","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112803","article-title":"Biomimetic fabrication of nanotherapeutics by leukocyte membrane cloaking for targeted therapy","volume":"219","author":"Mohale","year":"2022","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"10","key":"10.1016\/j.bioactmat.2026.06.040_bib53","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1136\/annrheumdis-2018-212988","article-title":"Apoptosis-derived membrane vesicles drive the cGAS-STING pathway and enhance type I IFN production in systemic lupus erythematosus","volume":"77","author":"Kato","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.bioactmat.2026.06.040_bib54","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.bbrc.2010.06.079","article-title":"Human plasma membrane-derived vesicles inhibit the phagocytosis of apoptotic cells--possible role in SLE","volume":"398","author":"Antwi-Baffour","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.bioactmat.2026.06.040_bib55","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1021\/acs.bioconjchem.7b00814","article-title":"Biomimetic nanosponges for treating antibody-mediated autoimmune diseases","volume":"29","author":"Jiang","year":"2018","journal-title":"Bioconjug. Chem."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.06.040_bib56","volume":"15","author":"Huang","year":"2024","journal-title":"Virulence"},{"issue":"1","key":"10.1016\/j.bioactmat.2026.06.040_bib57","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1186\/s40001-024-02124-8","article-title":"Application of targeted drug delivery by cell membrane-based biomimetic nanoparticles for inflammatory diseases and cancers","volume":"29","author":"Qiu","year":"2024","journal-title":"Eur. J. Med. Res."},{"issue":"22","key":"10.1016\/j.bioactmat.2026.06.040_bib58","doi-asserted-by":"crossref","first-page":"10106","DOI":"10.7150\/thno.48448","article-title":"Amelioration of ulcerative colitis via inflammatory regulation by macrophage-biomimetic nanomedicine","volume":"10","author":"Sun","year":"2020","journal-title":"Theranostics"},{"issue":"26","key":"10.1016\/j.bioactmat.2026.06.040_bib59","doi-asserted-by":"crossref","first-page":"eado6798","DOI":"10.1126\/sciadv.ado6798","article-title":"Oral microsphere formulation of M2 macrophage-mimetic Janus nanomotor for targeted therapy of ulcerative colitis","volume":"10","author":"Luo","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib60","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.actbio.2021.01.020","article-title":"Human neutrophil membrane-derived nanovesicles as a drug delivery platform for improved therapy of infectious diseases","volume":"123","author":"Gao","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib61","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1146\/annurev-immunol-042617-053010","article-title":"Apoptosis and clearance of apoptotic cells","volume":"36","author":"Nagata","year":"2018","journal-title":"Annu. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.bioactmat.2026.06.040_bib62","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nrrheum.2010.46","article-title":"The role of defective clearance of apoptotic cells in systemic autoimmunity","volume":"6","author":"Mu\u00f1oz","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib63","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3389\/fimmu.2019.01140","article-title":"The role of monocytes and macrophages in autoimmune diseases: a comprehensive review","volume":"10","author":"Ma","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.06.040_bib64","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13075-018-1796-4","article-title":"Endothelial activation and injury by microparticles in patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"21","author":"Atehort\u00faa","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib65","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.med.45.1.361","article-title":"Endothelial-leukocyte adhesion molecules in human disease","volume":"45","author":"Bevilacqua","year":"1994","journal-title":"Annu. Rev. Med."},{"issue":"4","key":"10.1016\/j.bioactmat.2026.06.040_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9040328","article-title":"Endothelial barrier function and leukocyte transmigration in atherosclerosis","volume":"9","author":"Sluiter","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib67","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9680729","article-title":"Endothelial alterations in systemic lupus erythematosus and rheumatoid arthritis: potential effect of monocyte interaction","volume":"2017","author":"Atehort\u00faa","year":"2017","journal-title":"Mediat. Inflamm."},{"issue":"9","key":"10.1016\/j.bioactmat.2026.06.040_bib68","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41584-021-00665-4","article-title":"Importance of lymphocyte-stromal cell interactions in autoimmune and inflammatory rheumatic diseases","volume":"17","author":"Noack","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"issue":"6","key":"10.1016\/j.bioactmat.2026.06.040_bib69","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.immuni.2018.04.009","article-title":"Autoimmune Th17 cells induced synovial stromal and innate lymphoid cell secretion of the cytokine GM-CSF to initiate and augment autoimmune arthritis","volume":"48","author":"Hirota","year":"2018","journal-title":"Immunity"},{"issue":"27","key":"10.1016\/j.bioactmat.2026.06.040_bib70","doi-asserted-by":"crossref","first-page":"13490","DOI":"10.1073\/pnas.1905301116","article-title":"Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology","volume":"116","author":"Nayar","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.bioactmat.2026.06.040_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103098","article-title":"The role of B cells and their interactions with stromal cells in the context of inflammatory autoimmune diseases","volume":"21","author":"Tout","year":"2022","journal-title":"Autoimmun. Rev."},{"issue":"3","key":"10.1016\/j.bioactmat.2026.06.040_bib72","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.152766","article-title":"The RNA-binding protein IMP2 drives a stromal-Th17 cell circuit in autoimmune neuroinflammation","volume":"7","author":"Bechara","year":"2022","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/j.bioactmat.2026.06.040_bib73","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.136059","article-title":"Mesenchymal stromal cells induce distinct myeloid-derived suppressor cells in inflammation","volume":"5","author":"Lee","year":"2020","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.bioactmat.2026.06.040_bib74","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.4049\/jimmunol.1402139","article-title":"Mesenchymal stem\/stromal cells protect against autoimmunity via CCL2-dependent recruitment of myeloid-derived suppressor cells","volume":"194","author":"Lee","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.643170","article-title":"Multipotent mesenchymal stromal cells in rheumatoid arthritis and systemic lupus erythematosus; from a leading role in pathogenesis to potential therapeutic saviors?","volume":"12","author":"El-Jawhari","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.658984","article-title":"Stromal cells underlining the paths from autoimmunity, inflammation to cancer with roles beyond structural and nutritional support","volume":"9","author":"Honan","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.06.040_bib77","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1186\/s12951-022-01746-6","article-title":"Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment","volume":"20","author":"Wu","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.139114","article-title":"Berberine-calcium alginate-coated macrophage membrane-derived nanovesicles for the oral treatment of ulcerative colitis","volume":"294","author":"Ma","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib79","first-page":"366","article-title":"Neddylation suppression by a macrophage membrane-coated nanoparticle promotes dual immunomodulatory repair of diabetic wounds","volume":"34","author":"Zeng","year":"2024","journal-title":"Bioact. Mater."},{"issue":"3","key":"10.1016\/j.bioactmat.2026.06.040_bib80","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1021\/acs.bioconjchem.7b00669","article-title":"Cell membrane bioconjugation and membrane-derived nanomaterials for immunotherapy","volume":"29","author":"Li","year":"2018","journal-title":"Bioconjug. Chem."},{"issue":"16","key":"10.1016\/j.bioactmat.2026.06.040_bib81","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1021\/acs.nanolett.5c00986","article-title":"Epigenetically reprogrammed nanovesicles as inverse vaccines for antigen-specific immune tolerance in autoimmune diseases","volume":"25","author":"Xi","year":"2025","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.06.040_bib82","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s42003-020-01410-5","article-title":"Co-delivery of resolvin D1 and antibiotics with nanovesicles to lungs resolves inflammation and clears bacteria in mice","volume":"3","author":"Gao","year":"2020","journal-title":"Commun. Biol."},{"issue":"2","key":"10.1016\/j.bioactmat.2026.06.040_bib83","first-page":"1272","article-title":"Neutrophil membrane-derived nanovesicles alleviate inflammation to protect mouse brain injury from ischemic stroke","volume":"13","author":"Dong","year":"2019","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.bioactmat.2026.06.040_bib84","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/s41565-018-0254-4","article-title":"Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis","volume":"13","author":"Zhang","year":"2018","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101791","article-title":"Delivery of neutrophil membrane encapsulated non-steroidal anti-inflammatory drugs by degradable biopolymer microneedle patch for rheumatoid arthritis therapy","volume":"49","author":"Lin","year":"2023","journal-title":"Nano Today"},{"issue":"4","key":"10.1016\/j.bioactmat.2026.06.040_bib86","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1021\/acsanm.2c04615","article-title":"Neutrophil membrane-coated mesoporous silica nanoparticles loaded with hydrocortisone alleviate DSS-induced colitis in mice","volume":"6","author":"Guozhen","year":"2023","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib87","article-title":"Biomimetic liposomes hybrid with erythrocyte membrane modulate dendritic cells to ameliorate systemic lupus erythematosus","volume":"20","author":"Hao","year":"2023","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib88","article-title":"Red blood cell membrane functionalized biomimetic nanoparticles for systemic lupus erythematosus treatment","volume":"16","author":"Xubin","year":"2022","journal-title":"Mater. Today Adv."},{"issue":"23","key":"10.1016\/j.bioactmat.2026.06.040_bib89","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201706759","article-title":"Cell membrane coating nanotechnology","volume":"30","author":"Fang","year":"2018","journal-title":"Adv. Mater."},{"issue":"37","key":"10.1016\/j.bioactmat.2026.06.040_bib90","doi-asserted-by":"crossref","first-page":"13481","DOI":"10.1073\/pnas.1412420111","article-title":"Clearance of pathological antibodies using biomimetic nanoparticles","volume":"111","author":"Copp","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2022.01.004","article-title":"Biomimetic platelet membrane-coated nanoparticles for targeted therapy","volume":"172","author":"Han","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib92","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.biomaterials.2016.10.003","article-title":"Nanoparticles camouflaged in platelet membrane coating as an antibody decoy for the treatment of immune thrombocytopenia","volume":"111","author":"Wei","year":"2016","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.bioactmat.2026.06.040_bib93","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1007\/s12274-018-2126-5","article-title":"Drug targeting through platelet membrane-coated nanoparticles for the treatment of rheumatoid arthritis","volume":"11","author":"He","year":"2018","journal-title":"Nano Res."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2023.213378","article-title":"\"Platelet-coated bullets\" biomimetic nanoparticles to ameliorate experimental colitis by targeting endothelial cells","volume":"148","author":"Song","year":"2023","journal-title":"Biomater. Adv."},{"issue":"20","key":"10.1016\/j.bioactmat.2026.06.040_bib95","doi-asserted-by":"crossref","first-page":"8609","DOI":"10.1021\/acs.nanolett.1c02482","article-title":"Hybrid vesicles based on autologous tumor cell membrane and bacterial outer membrane to enhance innate immune response and personalized tumor immunotherapy","volume":"21","author":"Zou","year":"2021","journal-title":"Nano Lett."},{"issue":"12","key":"10.1016\/j.bioactmat.2026.06.040_bib96","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/s41565-023-01523-y","article-title":"Ceria-vesicle nanohybrid therapeutic for modulation of innate and adaptive immunity in a collagen-induced arthritis model","volume":"18","author":"Koo","year":"2023","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.06.040_bib97","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12951-025-03123-5","article-title":"Neutrophil-macrophage hybrid membrane-coated prussian blue nanozyme for ulcerative colitis treatment and mechanistic insights","volume":"23","author":"Hu","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"16","key":"10.1016\/j.bioactmat.2026.06.040_bib98","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201606209","article-title":"Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization","volume":"29","author":"Dehaini","year":"2017","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib99","doi-asserted-by":"crossref","first-page":"12817","DOI":"10.2147\/IJN.S487598","article-title":"T lymphocyte-macrophage hybrid membrane-coated biomimetic nanoparticles alleviate myocarditis via suppressing pyroptosis by targeting gene silencing","volume":"19","author":"Xiong","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib100","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae666.3727","article-title":"Macrophage-T cell hybrid membrane-camouflaged biomimetic nanoparticles ameliorate autoimmune myocarditis via suppressing macrophage pyroptosis by target gene silencing","volume":"45","author":"Xiong","year":"2024","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.06.040_bib101","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1186\/s12951-024-02822-9","article-title":"Macrophage membrane-camouflaged biomimetic nanoparticles for rheumatoid arthritis treatment via modulating macrophage polarization","volume":"22","author":"Zhou","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"43","key":"10.1016\/j.bioactmat.2026.06.040_bib102","doi-asserted-by":"crossref","first-page":"11488","DOI":"10.1073\/pnas.1714267114","article-title":"Macrophage-like nanoparticles concurrently absorbing endotoxins and proinflammatory cytokines for sepsis management","volume":"114","author":"Thamphiwatana","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.06.040_bib103","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12951-024-02470-z","article-title":"Immunosuppressive microvesicles-mimetic derived from tolerant dendritic cells to target T-lymphocytes for inflammation diseases therapy","volume":"22","author":"Lin","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"2","key":"10.1016\/j.bioactmat.2026.06.040_bib104","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202402965","article-title":"Inflammation-targeted biomimetic nano-decoys via inhibiting the infiltration of immune cells and effectively delivering glucocorticoids for enhanced multiple sclerosis treatment","volume":"14","author":"Yang","year":"2025","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120395","article-title":"Platelet membrane camouflaged nanoparticles: biomimetic architecture for targeted therapy","volume":"598","author":"Kunde","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"Supplement_1","key":"10.1016\/j.bioactmat.2026.06.040_bib106","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae666.3727","article-title":"Macrophage-T cell hybrid membrane-camouflaged biomimetic nanoparticles ameliorate autoimmune myocarditis via suppressing macrophage pyroptosis by target gene silencing","volume":"45","author":"Xiong","year":"2024","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib107","article-title":"Macrophage cell membrane\u2010cloaked nanoplatforms for biomedical applications","volume":"6","author":"Joana","year":"2022","journal-title":"Small Methods"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib108","article-title":"Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines","volume":"11","author":"Cheng","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib109","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-022-01746-6","article-title":"Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment","volume":"20","author":"Wu","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib110","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-024-02470-z","article-title":"Immunosuppressive microvesicles-mimetic derived from tolerant dendritic cells to target T-lymphocytes for inflammation diseases therapy","volume":"22","author":"Lin","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib111","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70068","article-title":"Dendritic cell derived\u2010extracellular vesicles engineered to express Interleukin\u201012 and Anti\u2010CTLA\u20104 on their surface for combinational cancer immunotherapy","volume":"14","author":"Chen","year":"2025","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib112","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/bs.ircmb.2019.08.005","article-title":"Dendritic cell extracellular vesicles","volume":"349","author":"Kowal","year":"2019","journal-title":"Int. Rev. Cell Mol. Biol."},{"issue":"12","key":"10.1016\/j.bioactmat.2026.06.040_bib113","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202404510","article-title":"Neutrophil membrane-encapsulated polymerized salicylic acid nanoparticles effectively alleviating rheumatoid arthritis by facilitating sustained release of salicylic acid into the articular cavity from chondrocytes","volume":"14","author":"Yang","year":"2025","journal-title":"Adv. Healthcare Mater."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.06.040_bib114","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12951-023-01773-x","article-title":"Peptide-anchored neutrophil membrane-coated biomimetic nanodrug for targeted treatment of rheumatoid arthritis","volume":"21","author":"Yang","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"2","key":"10.1016\/j.bioactmat.2026.06.040_bib115","first-page":"1272","article-title":"Neutrophil membrane-derived nanovesicles alleviate inflammation to protect mouse brain injury from ischemic stroke","volume":"13","author":"Dong","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib116","article-title":"Blood concentrations of small extracellular vesicles are determined by a balance between abundant secretion and rapid clearance","volume":"9","author":"Akihiro","year":"2019","journal-title":"J. Extracell. Vesicles"},{"issue":"2","key":"10.1016\/j.bioactmat.2026.06.040_bib117","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1021\/acsnano.3c09848","article-title":"Engineered biomimetic nanovesicles based on neutrophils for hierarchical targeting therapy of acute respiratory distress syndrome","volume":"18","author":"Xiaonan","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib118","article-title":"Red blood cell-derived extracellular vesicles: an overview of current research progress, challenges, and opportunities","volume":"11","author":"Rui","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib119","article-title":"Extracellular vesicles from red blood cells and their evolving roles in health, coagulopathy and therapy","volume":"22","author":"Kiruphagaran","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib120","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.2147\/IJN.S504644","article-title":"Red blood cell membrane vesicles for siRNA delivery: a biocompatible carrier with passive tumor targeting and prolonged plasma residency","volume":"20","author":"Pelle Giulia","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib121","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.7150\/thno.52496","article-title":"Engineering extracellular vesicles with platelet membranes fusion enhanced targeted therapeutic angiogenesis in a mouse model of myocardial ischemia reperfusion","volume":"11","author":"Qiyu","year":"2021","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.bioactmat.2026.06.040_bib122","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/TA.0000000000002230","article-title":"Regulation of endothelial cell permeability by platelet-derived extracellular vesicles","volume":"86","author":"Miyazawa","year":"2019","journal-title":"J. Trauma Acute Care Surg."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib123","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/08982104.2025.2495261","article-title":"Hamed soleimani samarkhazan, platelet-derived extracellular vesicles: emerging players in hemostasis and thrombosis","volume":"35","author":"Kubaev","year":"2025","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib124","article-title":"Composition-dependent tunability of the cell interactions of hybrid lipid - block copolymer vesicles","volume":"694","author":"Juan","year":"2025","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib125","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202303617","article-title":"Beyond extracellular vesicles: hybrid membrane nanovesicles as emerging advanced tools for biomedical applications","volume":"10","author":"Sun","year":"2023","journal-title":"Adv. Sci."},{"issue":"14","key":"10.1016\/j.bioactmat.2026.06.040_bib126","doi-asserted-by":"crossref","first-page":"17129","DOI":"10.1021\/acsami.3c18569","article-title":"CXCR4-Targeted macrophage-derived biomimetic hybrid vesicle nanoplatform for enhanced cancer therapy through codelivery of manganese and doxorubicin","volume":"16","author":"Yeonwoo","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"9","key":"10.1016\/j.bioactmat.2026.06.040_bib127","doi-asserted-by":"crossref","DOI":"10.3390\/polym10090983","article-title":"Cell membrane-camouflaged nanoparticles: a promising biomimetic strategy for cancer theragnostics","volume":"10","author":"Vijayan","year":"2018","journal-title":"Polymers"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116951","article-title":"Recent advances in biomimetic cell membrane-camouflaged nanoparticles for cancer therapy","volume":"177","author":"Alimohammadvand","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2020.05.028","article-title":"Hybrid cell membrane-coated nanoparticles: a multifunctional biomimetic platform for cancer diagnosis and therapy","volume":"112","author":"Chen","year":"2020","journal-title":"Acta Biomater."},{"issue":"4","key":"10.1016\/j.bioactmat.2026.06.040_bib130","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16040531","article-title":"Cell membrane-coated biomimetic nanoparticles in cancer treatment","volume":"16","author":"Zhang","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib131","article-title":"Stealth missiles with precision guidance: a novel multifunctional nano-drug delivery system based on biomimetic cell membrane coating technology","volume":"33","author":"Zhou","year":"2025","journal-title":"Mater. Today Bio"},{"issue":"1","key":"10.1016\/j.bioactmat.2026.06.040_bib132","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00232-006-0080-8","article-title":"Membrane reserves and hypotonic cell swelling","volume":"214","author":"Groulx","year":"2006","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib133","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.actbio.2022.02.028","article-title":"Cellular membrane-based vesicles displaying a reconstructed B cell maturation antigen for multiple myeloma therapy by dual targeting APRIL and BAFF","volume":"143","author":"He","year":"2022","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.06.040_bib134","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010005","article-title":"Plasma membrane-coated nanoparticles and membrane vesicles to orchestrate multimodal antitumor immunity","volume":"13","author":"Ito","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.bioactmat.2026.06.040_bib135","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/sji.12068","article-title":"The role of microparticles in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus","volume":"78","author":"Dye","year":"2013","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121517","article-title":"Engineered PD-1\/TIGIT dual-activating cell-membrane nanoparticles with dexamethasone act synergistically to shape the effector T Cell\/treg balance and alleviate systemic lupus erythematosus","volume":"285","author":"Guo","year":"2022","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.bioactmat.2026.06.040_bib137","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s42003-023-04859-2","article-title":"High efficiency preparation of monodisperse plasma membrane derived extracellular vesicles for therapeutic applications","volume":"6","author":"Alter","year":"2023","journal-title":"Commun. Biol."},{"issue":"12","key":"10.1016\/j.bioactmat.2026.06.040_bib138","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15122770","article-title":"Cell membrane biomimetic nano-delivery systems for cancer therapy","volume":"15","author":"Xia","year":"2023","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.bioactmat.2026.06.040_bib139","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1021\/jacs.4c13644","article-title":"A granzyme B-Cleavable T cell-targeted bispecific cell vesicle connector for reversing new-onset type 1 diabetes","volume":"147","author":"Wang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"14","key":"10.1016\/j.bioactmat.2026.06.040_bib140","doi-asserted-by":"crossref","first-page":"17129","DOI":"10.1021\/acsami.3c18569","article-title":"CXCR4-Targeted macrophage-derived biomimetic hybrid vesicle nanoplatform for enhanced cancer therapy through codelivery of manganese and doxorubicin","volume":"16","author":"Yeonwoo","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"7","key":"10.1016\/j.bioactmat.2026.06.040_bib141","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41565-024-01648-8","article-title":"Multimodal nanoimmunotherapy engages neutrophils to eliminate Staphylococcus aureus infections","volume":"19","author":"Zhu","year":"2024","journal-title":"Nat. Nanotechnol."},{"issue":"11","key":"10.1016\/j.bioactmat.2026.06.040_bib142","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1440-1746.1996.tb00042.x","article-title":"Keratinocyte growth factor is an endogenous stimulant of rabbit gastric epithelial cell proliferation and migration in primary culture","volume":"11","author":"Takahashi","year":"1996","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib143","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.ijbiomac.2021.09.151","article-title":"Keratinocyte growth factor in focus: a comprehensive review from structural and functional aspects to therapeutic applications of palifermin","volume":"191","author":"Sadeghi","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib144","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jconrel.2019.02.034","article-title":"Ulcerative colitis-specific delivery of keratinocyte growth factor by neutrophils-simulated liposomes facilitates the morphologic and functional recovery of the damaged colon through alleviating the inflammation","volume":"299","author":"Zhao","year":"2019","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib145","doi-asserted-by":"crossref","first-page":"102","DOI":"10.34133\/bmr.0102","article-title":"Cell membrane-coated nanotherapeutics for the targeted treatment of acute and chronic colitis","volume":"28","author":"Li","year":"2024","journal-title":"Biomater. Res."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib146","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jconrel.2021.08.008","article-title":"OX40L blockade cellular nanovesicles for autoimmune diseases therapy","volume":"337","author":"Fu","year":"2021","journal-title":"J. Contr. Release"},{"issue":"10","key":"10.1016\/j.bioactmat.2026.06.040_bib147","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202305197","article-title":"Ingenious synergy of a pathology-specific biomimetic multifunctional nanoplatform for targeted therapy in rheumatoid arthritis","volume":"20","author":"Xu","year":"2024","journal-title":"Small"},{"issue":"15","key":"10.1016\/j.bioactmat.2026.06.040_bib148","article-title":"Biomimetic nanoplatform for targeted rheumatoid arthritis therapy: modulating macrophage niches through self-sustaining positive feedback-driven drug release mechanisms","volume":"12","author":"Xie","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib149","article-title":"Biomimetic and inflammation-targeted nanoparticles for rheumatoid arthritis therapy via M1-macrophages apoptosis and polarization","volume":"239","author":"Xuefang","year":"2024","journal-title":"Mater. Des."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.06.040_bib150","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1021\/acs.nanolett.8b03439","article-title":"Route to rheumatoid arthritis by macrophage-derived microvesicle-coated nanoparticles","volume":"19","author":"Li","year":"2019","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.06.040_bib151","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s13346-024-01605-x","article-title":"Revolutionizing rheumatoid arthritis therapy: harnessing cytomembrane biomimetic nanoparticles for novel treatment strategies","volume":"15","author":"Ma","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"issue":"20","key":"10.1016\/j.bioactmat.2026.06.040_bib152","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1001\/jama.2022.14236","article-title":"What is multiple sclerosis?","volume":"328","author":"Marcus","year":"2022","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.bioactmat.2026.06.040_bib153","doi-asserted-by":"crossref","first-page":"7515","DOI":"10.1039\/D3NR05351B","article-title":"Graphene oxide films as a novel tool for the modulation of myeloid-derived suppressor cell activity in the context of multiple sclerosis","volume":"16","author":"Camacho-Toledano","year":"2024","journal-title":"Nanoscale"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122997","article-title":"Mesoporous polydopamine nanoparticle-based tolerogenic vaccine induces antigen-specific immune tolerance to prevent and treat autoimmune multiple sclerosis","volume":"316","author":"Phan","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib155","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10741-012-9364-5","article-title":"Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management","volume":"18","author":"Caforio","year":"2013","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib156","article-title":"Nanoparticle-based drug delivery systems targeting inflammatory immune mechanisms in acute myocardial infarction: current advances and perspectives","volume":"12","author":"Yuxuan","year":"2025","journal-title":"Front. Cardiovasc. Med."},{"issue":"13","key":"10.1016\/j.bioactmat.2026.06.040_bib157","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.1039\/D3NR05391A","article-title":"Macrophage membrane-modified targeted phase-change nanoparticles for multimodal imaging of experimental autoimmune myocarditis","volume":"16","author":"Yin","year":"2024","journal-title":"Nanoscale"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib158","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.7150\/thno.51571","article-title":"Targeted delivery of extracellular vesicles in heart injury","volume":"11","author":"Chen","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib159","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1080\/17425247.2025.2555488","article-title":"Clinical insights into extracellular vesicles for targeted myocardial drug delivery","volume":"22","author":"Haoran","year":"2025","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib160","article-title":"Minimally invasive delivery of therapeutic agents by hydrogel injection into the pericardial cavity for cardiac repair","volume":"12","author":"Zhu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib161","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.actbio.2024.12.009","article-title":"Sequential delivery of cardioactive drugs via microcapped microneedle patches for improved heart function in post myocardial infarction rats","volume":"192","author":"He","year":"2024","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib162","first-page":"9","article-title":"Immunomodulatory microneedle patch for cardiac repair in rodent and porcine models of myocardial infarction","volume":"1","author":"Huang","year":"2025","journal-title":"Cell Biomater."},{"issue":"9","key":"10.1016\/j.bioactmat.2026.06.040_bib163","article-title":"Immunomodulatory microneedle patch for cardiac repair in rodent and porcine models of myocardial infarction","volume":"1","author":"Huang","year":"2025","journal-title":"Cell Biomater."},{"issue":"9","key":"10.1016\/j.bioactmat.2026.06.040_bib164","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1161\/CIRCULATIONAHA.123.065005","article-title":"Inhalable stem cell exosomes promote heart repair after myocardial infarction","volume":"150","author":"Li","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib165","first-page":"45","article-title":"Stromal-platelet membrane-inspired nanoparticles (SPIN) for targeted heart repair","volume":"53","author":"He","year":"2025","journal-title":"Bioact. Mater."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.06.040_bib166","doi-asserted-by":"crossref","first-page":"7678","DOI":"10.1038\/s41467-025-62020-5","article-title":"Plant-derived hydrogel and photosynthetic nano-units for myocardial infarction therapy","volume":"16","author":"Lv","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib167","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2026.01.033","article-title":"Avenues for optimization of cardiac therapeutics by minimally invasive delivery","volume":"212","author":"Li","year":"2026","journal-title":"Acta Biomater."},{"issue":"02","key":"10.1016\/j.bioactmat.2026.06.040_bib168","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1042\/EBC20253016","article-title":"Immune-regulating extracellular vesicles: a new frontier in autoimmune disease therapy","volume":"69","author":"Hassan","year":"2025","journal-title":"Essays Biochem."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib169","article-title":"Cell membrane biomimetic nanoplatforms: a new strategy for immune escape and precision targeted therapy","volume":"35","author":"Feng","year":"2025","journal-title":"Mater. Today Bio"},{"issue":"4","key":"10.1016\/j.bioactmat.2026.06.040_bib210","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1021\/acsnano.3c05847","article-title":"Multitargeted immunomodulatory therapy for viral myocarditis by engineered extracellular vesicles","volume":"18","author":"Pei","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib211","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-023-02105-9","article-title":"Critical contributions of protein cargos to the functions of macrophage-derived extracellular vesicles","volume":"21","author":"Liu","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib212","article-title":"Extracellular vesicle\/macrophage axis: potential targets for inflammatory disease intervention","volume":"13","author":"Tang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib213","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.actbio.2021.01.020","article-title":"Human neutrophil membrane-derived nanovesicles as a drug delivery platform for improved therapy of infectious diseases","volume":"123","author":"Jin","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib214","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102826","article-title":"Neutrophil-derived extracellular vesicles induce endothelial inflammation and damage through the transfer of miRNAs","volume":"129","author":"Gl\u00e9main","year":"2022","journal-title":"J. Autoimmun."},{"issue":"6","key":"10.1016\/j.bioactmat.2026.06.040_bib215","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.cell.2025.01.021","article-title":"Neutrophil-derived vesicles control complement activation to facilitate inflammation resolution","volume":"188","author":"Hsu","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib181","doi-asserted-by":"crossref","first-page":"46222","DOI":"10.1021\/acsomega.2c04420","article-title":"Dendritic cell membrane-derived nanovesicles for targeted T cell activation","volume":"7","author":"Harvey","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib216","article-title":"Dendritic cell membrane vesicles for activation and maintenance of antigen\u2010specific T cells","volume":"8","author":"Lukasz","year":"2018","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib217","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.actbio.2019.04.033","article-title":"Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8+ T cells","volume":"91","author":"Schetters","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib218","article-title":"The emerging roles of platelet-derived extracellular vesicles in disease","volume":"57","author":"Can","year":"2025","journal-title":"Ann. Med."},{"issue":"7","key":"10.1016\/j.bioactmat.2026.06.040_bib219","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/j.matt.2022.05.018","article-title":"Dressing blood-contacting devices with platelet membrane enables large-scale multifunctional biointerfacing","volume":"5","author":"Zhong","year":"2022","journal-title":"Matter"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib220","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.3324\/haematol.2018.215145","article-title":"Appropriation of GPIb\u03b1 from platelet-derived extracellular vesicles supports monocyte recruitment in systemic inflammation","volume":"105","author":"Chimen","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib221","article-title":"Cell membrane-derived nanovehicles for targeted therapy of ischemic stroke: from construction to application","volume":"16","author":"Cui","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib222","article-title":"Red blood cell-derived materials for cancer therapy: construction, distribution, and applications","volume":"24","author":"Jia-Ning","year":"2023","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib223","article-title":"Drug-loaded erythrocytes: modern approaches for advanced drug delivery for clinical use","volume":"10","author":"Berikkhanova","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib224","article-title":"Extracellular vesicles hybrid plasmid-loaded lipid nanovesicles for synergistic cancer immunotherapy","volume":"23","author":"Tong","year":"2023","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib225","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70175","article-title":"Hybrid extracellular vesicles with combined functional properties from mesenchymal stem cells and astrocytes for targeted neurodegenerative disease applications","volume":"14","author":"Wang","year":"2025","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib226","article-title":"Engineered CAF-Cancer cell hybrid membrane biomimetic dual-targeted integrated platform for multi-dimensional treatment of ovarian cancer","volume":"23","author":"Yuwei","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib170","article-title":"Immunogenicity of extracellular vesicles","volume":"36","author":"Yutian","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib171","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122718","article-title":"The functional heterogeneity of neutrophil-derived extracellular vesicles reflects the status of the parent cell","volume":"9","author":"Kolonics","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib172","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1479330","article-title":"Macrophage-derived extracellular vesicles as new players in chronic non-communicable diseases","volume":"15","author":"Lin","year":"2025","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bioactmat.2026.06.040_bib173","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.immuni.2024.03.002","article-title":"DAMPs and DAMP-sensing receptors in inflammation and diseases","volume":"57","author":"Ming","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib174","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12513","article-title":"Beyond basic characterization and omics: immunomodulatory roles of platelet\u2010derived extracellular vesicles unveiled by functional testing","volume":"13","author":"Palviainen","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib175","article-title":"Red blood cell-derived extracellular vesicles for gene and RNA therapeutics: biological, engineering, and translational challenges","volume":"21","author":"Tayyab","year":"2026","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib176","article-title":"Engineered hybrid membrane vesicles combined with autologous and synthetic antigens as therapeutic vaccines to efficiently suppress tumor recurrence","author":"Shi-Hao","year":"2025","journal-title":"J. Contr. Release : Off. J. Contr. Rel. Soc."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib177","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.7150\/thno.68667","article-title":"Surface-engineered extracellular vesicles for targeted delivery of therapeutic RNAs and peptides for cancer therapy","volume":"12","author":"Jayasinghe","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib178","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-023-00972-w","article-title":"Expanding applications of allogeneic platelets, platelet lysates, and platelet extracellular vesicles in cell therapy, regenerative medicine, and targeted drug delivery","volume":"30","author":"Burnouf","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib179","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1039\/D5BM01349F","article-title":"Red blood cell-derived extracellular vesicles as biomaterials: the opportunity of freezing-induced accelerated aging","volume":"14","author":"Lucia","year":"2026","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib180","article-title":"Protocol for the isolation of human neutrophil-derived extracellular vesicles for characterization and functional experimentation","volume":"6","author":"Robert","year":"2025","journal-title":"STAR Protoc."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.06.040_bib182","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/s12951-023-02105-9","article-title":"Critical contributions of protein cargos to the functions of macrophage-derived extracellular vesicles","volume":"21","author":"Liu","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"10","key":"10.1016\/j.bioactmat.2026.06.040_bib183","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70175","article-title":"Hybrid extracellular vesicles with combined functional properties from mesenchymal stem cells and astrocytes for targeted neurodegenerative disease applications","volume":"14","author":"Wang","year":"2025","journal-title":"J. Extracell. Vesicles"},{"issue":"1","key":"10.1016\/j.bioactmat.2026.06.040_bib184","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1038\/s41467-024-49123-1","article-title":"Optimizing cell therapy by sorting cells with high extracellular vesicle secretion","volume":"15","author":"Koo","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26031272","article-title":"Unveiling the phenotypic variability of macrophages: insights from donor diversity and pooling strategies","volume":"26","author":"Taciak","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib186","article-title":"Heterogeneous populations from in vitro cultures of antigen presenting cells in pigs","volume":"234","author":"Myriam","year":"2021","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib187","article-title":"Leveraging nature's nanocarriers: translating insights from extracellular vesicles to biomimetic synthetic vesicles for biomedical applications","volume":"11","author":"Chen","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib188","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-023-02081-0","article-title":"Targeted therapy using engineered extracellular vesicles: principles and strategies for membrane modification","volume":"21","author":"Liu","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib189","article-title":"Bottom\u2010up synthesis and purification of extracellular vesicle mimetics","volume":"14","author":"Lin Stiemsma","year":"2025","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib190","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ebiom.2018.02.003","article-title":"Neutrophil microvesicles from healthy control and rheumatoid arthritis patients prevent the inflammatory activation of macrophages","volume":"29","author":"Rhys","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib191","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac5608","article-title":"Neutrophil-derived microvesicles enter cartilage and protect the joint in inflammatory arthritis","volume":"7","author":"Headland","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib192","doi-asserted-by":"crossref","first-page":"408","DOI":"10.7150\/thno.103747","article-title":"Platelet membrane decorated exosomes enhance targeting efficacy and therapeutic index to alleviate arterial restenosis","volume":"15","author":"Sha","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib193","article-title":"Red blood cell-derived materials for cancer therapy: construction, distribution, and applications","volume":"24","author":"Ding","year":"2024","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib194","article-title":"Biodistribution of extracellular vesicles following administration into animals: a systematic review","volume":"10","author":"Matt","year":"2021","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib195","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1039\/D5BM00660K","article-title":"Advances in cell membrane-coated nanoparticles: multifunctional platforms for targeted drug delivery, precision phototherapy, and enhanced immunotherapy","volume":"13","author":"Sultana","year":"2025","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib196","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202304477","article-title":"Hybrid cell membrane\u2010based nanoplatforms for enhanced immunotherapy against cancer and infectious diseases","volume":"13","author":"Peng","year":"2024","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib197","article-title":"Recent advances in AI-driven protein-ligand interaction predictions","volume":"92","author":"Jaemin","year":"2025","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib198","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114974","article-title":"Towards artificial intelligence-enabled extracellular vesicle precision drug delivery","author":"Greenberg","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"10.1016\/j.bioactmat.2026.06.040_bib199","doi-asserted-by":"crossref","first-page":"6857","DOI":"10.1021\/acs.est.0c07040","article-title":"Developing QSAR models with defined applicability domains on PPAR\u03b3 binding affinity using large data sets and machine learning algorithms","volume":"55","author":"Wang","year":"2021","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib200","doi-asserted-by":"crossref","first-page":"7262","DOI":"10.1021\/acs.jmedchem.2c00254","article-title":"Quantitative structure\u2013activity relationship (QSAR) study predicts small-molecule binding to RNA structure","volume":"65","author":"Cai","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib201","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15030984","article-title":"The CRISPR\/Cas9 system delivered by extracellular vesicles","volume":"15","author":"Zhu","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioactmat.2026.06.040_bib202","doi-asserted-by":"crossref","first-page":"7737","DOI":"10.1021\/acs.jmedchem.5c00340","article-title":"Application of machine learning and mechanistic modeling to predict intravenous pharmacokinetic profiles in humans","volume":"68","author":"Jia","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib203","first-page":"1369","article-title":"A combination of machine learning and PBPK modeling approach for pharmacokinetics prediction of small molecules in humans","volume":"41","author":"Yuelin","year":"2023","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib204","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s11095-024-03757-4","article-title":"Quality and safety considerations for therapeutic products based on extracellular vesicles","volume":"41","author":"Takakura","year":"2024","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bioactmat.2026.06.040_bib205","article-title":"Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies","volume":"10","author":"Gangling","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"2","key":"10.1016\/j.bioactmat.2026.06.040_bib206","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.fmre.2024.03.025","article-title":"Engineering exosomes and exosome-like nanovesicles for improving tissue targeting and retention","volume":"5","author":"Li","year":"2025","journal-title":"Fundam. Res."},{"issue":"32","key":"10.1016\/j.bioactmat.2026.06.040_bib207","article-title":"Decoy exosomes offer protection against chemotherapy-induced toxicity","volume":"9","author":"Fan","year":"2022","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"9","key":"10.1016\/j.bioactmat.2026.06.040_bib208","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.1021\/acsnano.3c06462","article-title":"Anticancer therapy targeting cancer-derived extracellular vesicles","volume":"18","author":"Cheng","year":"2024","journal-title":"ACS Nano"},{"issue":"31","key":"10.1016\/j.bioactmat.2026.06.040_bib209","doi-asserted-by":"crossref","first-page":"28021","DOI":"10.1021\/acsnano.5c00706","article-title":"Extracellular vesicles for clinical diagnostics: from bulk measurements to single-vesicle analysis","volume":"19","author":"Tran","year":"2025","journal-title":"ACS Nano"}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X26003762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X26003762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:10:10Z","timestamp":1792080610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X26003762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":226,"alternative-id":["S2452199X26003762"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2026.06.040","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune cell-derived membrane nanovesicles: A promethean fire for autoimmune disease therapy through immune cell mimicry","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2026.06.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}